A TLR9-adjuvanted vaccine formulated into dissolvable microneedle patches or cationic liposomes protects against leishmaniasis after skin or subcutaneous immunization
Juliane S. Lanza, Sonja Vučen, Olivia Flynn, Agnese Donadei, Sandrine Cojean, Philippe M. Loiseau, Ana Paula Fernandes, Fréderic Frézard, Anne Moore
Topics & Concepts
Cationic liposomeCpG OligodeoxynucleotideLiposomeAntigenAdjuvantImmunizationLeishmania donovaniReactogenicityLeishmania mexicanaCutaneous leishmaniasisMedicineLeishmaniasisImmunologyLeishmaniaVirologyVisceral leishmaniasisBiologyParasite hostingGenetic enhancementGeneComputer scienceGene expressionBiochemistryDNA methylationWorld Wide WebResearch on Leishmaniasis StudiesToxin Mechanisms and ImmunotoxinsTransgenic Plants and Applications